CSL:ASX
CSL Ltd
A$175.59
arrow_downward
-1.11%(-1.97) 1D
Sep 18, 4:11:29 PM GMT+10 · AUD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSL...
Open
A$177.70
High
A$177.89
Low
A$174.39
Mkt. cap
84.26B
Avg. vol.
1.44M
Volume
4.25M
Dividend
1.62%
Quarterly dividend
A$0.71
Ex-dividend date
Sep 9, 2026
52-wk high
A$222.47
52-wk low
A$90.00
EPS
-A$7.51
Shares outstanding
479.88M
No. of employees
29K
Open
A$177.70
High
A$177.89
Low
A$174.39
Mkt. cap
84.26B
Avg. vol.
1.44M
Volume
4.25M
Dividend
1.62%
Quarterly dividend
A$0.71
Ex-dividend date
Sep 9, 2026
52-wk high
A$222.47
52-wk low
A$90.00
EPS
-A$7.51
Shares outstanding
479.88M
No. of employees
29K
News stories
From web sources and news partners
TheBull.com.au
·
1 day ago
CSL Shares Move Positive On Year, A Bulls Eye Breakout
CarePlus VietNam
·
2 months ago
CSL Q1 2026 Earnings: EPS Surpasses Estimates by 7.83%, Driving Positive Stock Movement - Trough Earnings Signal
Profile
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994. Wikipedia
About CSL Ltd
CEOPaul McKenzie
Employees29K
Founded1916
HeadquartersMelbourne, Victoria, Australia
SectorBiotechnology
Websitecsl.com